Clovis Oncology partnered with Qiagen to develop and commercialize a companion diagnostic for Clovis' CO-1686

Clovis Oncology Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Qiagen N.V.

the Netherlands / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced